Tonix Pharmaceuticals Holding Corp.
TNXP
Revenue
2.21M
▼-274.00k▼-11.04%
3 Months ChangeAssets
70.31M
▼-65.04M▼-48.05%
3 Months ChangeLiabilities
28.20M
▲1.00M▲3.69%
3 Months ChangeFree Cash Flow
-17.68M
▲19.03M▲51.83%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001839882-24-036731
2024-10-30
Form 8-K
ID: 0001999371-24-014188
2024-10-28
Form 8-K
ID: 0001999371-24-014008
2024-10-17
Form 8-K
ID: 0001839882-24-034021
2024-10-16
Form 8-K
ID: 0001839882-24-033909
2024-10-08
Form 8-K
ID: 0001839882-24-032980
2024-09-27
Form 8-K
ID: 0001839882-24-031012
2024-09-23
Form 8-K
ID: 0001839882-24-030149
2024-09-19
Form 8-K
ID: 0001839882-24-029804
2024-09-16
Form 8-K
ID: 0001839882-24-029343